Literature DB >> 15469733

Mitochondrial damage and metabolic compensatory mechanisms induced by hyperoxia in the U-937 cell line.

Roberto Scatena1, Irene Messana, Giuseppe Ettore Martorana, Maria Luisa Gozzo, Silvio Lippa, Alessandro Maccaglia, Patrizia Bottoni, Federica Vincenzoni, Giuseppina Nocca, Massimo Castagnola, Bruno Giardina.   

Abstract

Experimental hyperoxia represents a suitable in vitro model to study some pathogenic mechanisms related to oxidative stress. Moreover, it allows the investigation of the molecular pathophysiology underlying oxygen therapy and toxicity. In this study, a modified experimental set up was adopted to accomplish a model of moderate hyperoxia (50% O(2), 96 h culture) to induce oxidative stress in the human leukemia cell line, U-937. Spectrophotometric measurements of mitochondrial respiratory enzyme activities, NMR spectroscopy of culture media, determination of antioxidant enzyme activities, and cell proliferation and differentiation assays were performed. The data showed that moderate hyperoxia in this myeloid cell line causes: i) intriguing alterations in the mitochondrial activities at the levels of succinate dehydrogenase and succinate-cytochrome c reductase; ii) induction of metabolic compensatory adaptations, with significant shift to glycolysis; iii) induction of different antioxidant enzyme activities; iv) significant cell growth inhibition and v) no significant apoptosis. This work will permit better characterization the mitochondrial damage induced by hyperoxia. In particular, the data showed a large increase in the succinate cytochrome c reductase activity, which could be a fundamental pathogenic mechanism at the basis of oxygen toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469733     DOI: 10.5483/bmbrep.2004.37.4.454

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  8 in total

1.  Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension.

Authors:  Joshua P Fessel; Charles R Flynn; Linda J Robinson; Niki L Penner; Santhi Gladson; Christie J Kang; David H Wasserman; Anna R Hemnes; James D West
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

2.  Proteomic analysis of mitochondrial proteins in the guinea pig heart following long-term normobaric hyperoxia.

Authors:  Lucia Lichardusova; Zuzana Tatarkova; Andrea Calkovska; Daniela Mokra; Ivan Engler; Peter Racay; Jan Lehotsky; Peter Kaplan
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

3.  Mitochondrial DNA damage mediates hyperoxic dysmorphogenesis in rat fetal lung explants.

Authors:  Sarah A Gebb; Ashley Decoux; Alicia Waggoner; Glenn L Wilson; Mark N Gillespie
Journal:  Neonatology       Date:  2012-11-15       Impact factor: 4.035

4.  Col V siRNA engineered tenocytes for tendon tissue engineering.

Authors:  Ping Lu; Guo Rong Zhang; Xing Hui Song; Xiao Hui Zou; Lin Lin Wang; Hong Wei Ouyang
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

5.  Hyperoxia decreases glycolytic capacity, glycolytic reserve and oxidative phosphorylation in MLE-12 cells and inhibits complex I and II function, but not complex IV in isolated mouse lung mitochondria.

Authors:  Kumuda C Das
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

Review 6.  Effect of elevated oxygen concentration on bacteria, yeasts, and cells propagated for production of biological compounds.

Authors:  Antonino Baez; Joseph Shiloach
Journal:  Microb Cell Fact       Date:  2014-12-19       Impact factor: 5.328

7.  Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches.

Authors:  Li Yue; Xuexin Lu; Phyllis A Dennery; Hongwei Yao
Journal:  Redox Biol       Date:  2021-08-13       Impact factor: 11.799

8.  The Comparison of MTT and CVS Assays for the Assessment of Anticancer Agent Interactions.

Authors:  Lidia Śliwka; Katarzyna Wiktorska; Piotr Suchocki; Małgorzata Milczarek; Szymon Mielczarek; Katarzyna Lubelska; Tomasz Cierpiał; Piotr Łyżwa; Piotr Kiełbasiński; Anna Jaromin; Anna Flis; Zdzisław Chilmonczyk
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.